Rotarix Market Report 2026

Rotarix Market Overview

• The Rotarix market growth in the historic period has been driven by expansion of national immunization schedules, rising awareness of rotavirus disease burden • Market expansion is supported by increasing focus on disease prevention in infants, expansion of vaccination coverage in emerging markets • Growth Driver: Rising Rotavirus-Related Deaths Drive Growth Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rotarix Market?

Rotarix refers to a vaccine that is used to prevent rotavirus infections, which can cause severe diarrhea and dehydration in infants and young children. It is used for protecting against rotavirus gastroenteritis, helping to reduce hospitalizations and severe illness associated with the virus. The main clinical indication of rotarix include prevention of severe gastroenteritis, and cross-protection. Prevention of severe gastroenteritis refers to measures and strategies aimed at reducing the risk of developing or spreading severe gastrointestinal infections caused by viruses, bacteria, or parasites. The various formulations include liquid formulation, and lyophilized formulation and are distributed through several channels such as hospitals, clinics, and pharmacies.

What Is The Rotarix Market Growth Forecast?

The growth in the forecast period can be attributed to increasing focus on disease prevention in infants, expansion of vaccination coverage in emerging markets, growing investments in vaccine manufacturing capacity, rising government funding for immunization programs, continued innovation in oral vaccine formulations. Major trends in the forecast period include expansion of universal childhood vaccination programs, rising focus on oral vaccine delivery, growing emphasis on preventive pediatric care, improved cold-chain vaccine distribution systems, enhanced monitoring of immunization coverage.

Global Rotarix Market Segmentation

1) By Clinical Indication: Prevention Of Severe Gastroenteritis, Cross-Protection 2) By Formulation: Liquid Formulation, Lyophilized Formulation 3) By Distribution Channel: Hospitals, Clinics, Pharmacies

What Are The Drivers Of The Rotarix Market?

The increasing number of rotavirus-related deaths is expected to propel the growth of the rotarix market going forward. Rotavirus-related deaths refer to fatalities caused by severe dehydration and complications from rotavirus infection, particularly in young children. Increasing rotavirus-related deaths result from low vaccination coverage, limited access to healthcare, poor infrastructure, and inadequate treatment for dehydration. Rotarix is administered orally in two doses to infants, helping to prevent severe rotavirus infections by stimulating the immune system to produce antibodies against the virus. For instance, in August 2024, according to the GOV.UK, a UK-based government agency, the cumulative number of rotavirus laboratory reports in England up to week 21 of 2024 was 7% higher than the 5-season average. Additionally, rotavirus activity in weeks 18 to 21 of 2024 was 28% above the 5-season average and 37% higher compared to the previous 4-week period. Therefore, the increasing number of rotavirus-related deaths is driving the growth of the rotarix industry. The increasing healthcare expenditure is expected to propel the growth of the rotarix market going forward. Healthcare expenditure is the total spending on medical services, healthcare products, and related services, encompassing both public and private investments in treatment, prevention, and healthcare infrastructure. Healthcare expenditure is rising due to the aging population, which increases the demand for medical services, and advancements in medical technology, which drive up the costs of treatments and procedures. Rotarix helps healthcare expenditure by significantly reducing the incidence of rotavirus infections in infants and young children, thereby minimizing hospitalizations, emergency care, and the need for costly treatments associated with severe gastroenteritis, ultimately lowering the overall financial burden on healthcare systems. For instance, in January 2025, according to the National Institutes of Health (NIH), a U.S.-based federal biomedical research agency, in 2023, national health-care spending reached US $4.9 trillion, a 7.5 percent increase from 2022. Therefore, the increasing healthcare expenditure is driving the growth of the rotarix industry. The increasing incidence of diarrhea in children is expected to propel the growth of the Rotarix market going forward. Diarrhea in children refers to the passage of three or more loose or watery stools in 24 hours and is often caused by infections, poor hygiene, or dietary issues, leading to risks like dehydration. Diarrhea in children is increasing due to limited access to clean and safe drinking water, which exposes them to disease-causing germs and leads to more frequent infections. Rotarix supports the prevention of diarrhea in children by protecting them against rotavirus, a major cause of severe diarrheal illness, thereby reducing both the frequency and intensity of infections. For instance, in March 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year, diarrhea claims the lives of about 443,832 children under the age of five, along with another 50,851 children between five and nine years old. Therefore, the increasing incidence of diarrhea in children is driving the growth of the Rotarix industry.

Key Players In The Global Rotarix Market

Major companies operating in the rotarix market are GlaxoSmithKline plc

Regional Insights

North America was the largest region in the rotarix market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rotarix Market?

The rotavirus market consists of sales of products including syringes, needles, cold chain equipment, vials and ampoules, and sterilization equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rotarix Market Report 2026?

The rotarix market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rotarix industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.